bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Clinical trial NCT06070636 · RECRUITING

Trial details

NCT number: NCT06070636
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver Diseases Hepatocellular Carcinoma Immunotherapy Lenvatinib Sintilimab

Start date: 2024-05-20
Primary completion: 2025-01-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.